February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 11, 2025

Rare Pulmonary Lesions in CNO Show Favorable Outcomes

Pulmonary lesions in chronic nonbacterial osteomyelitis are rare and often asymptomatic, with most resolving over time, researchers report.

Conexiant

January 28, 2025

Medicare Study Compares LVRS, EBV Outcomes

"Medicare beneficiaries who undergo EBV present with fewer comorbidities, but after risk adjustment they have higher mortality and procedure-related morbidity than those undergoing LVRS," finds study of 3,219 patients comparing contemporary surgical outcomes.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

July 26, 2024

EHR Use Disparities: Female vs. Male Surgeons

A recent study published in JAMA Network Open reveals gender differences in electronic health record (EHR) usage among surgeons, with female surgeons writing significantly longer progress notes than their male counterparts.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

July 24, 2024

New Guideline Provides Recommendations for Managing Central Airway Obstruction

Learn about evidence-based recommendations for managing central airway obstruction in a new clinical guideline from the American College of Chest Physicians.

Conexiant

August 19, 2024

Treprostinil Approval Stalled by FDA

Liquidia’s treprostinil inhaler received tentative approval but faced exclusivity hurdles.

Reuters